氨溴索联合利巴韦林雾化吸入治疗婴幼儿毛细支气管炎临床疗效分析

Clinical analysis of inhalation with ambroxol and ribavirin for treatment of children bronchiolitis

目的:观察盐酸氨溴索联合利巴韦林雾化吸入治疗婴幼儿毛细支气管炎的临床疗效。方法:选择婴幼儿毛细支气管炎69例,随机分为对照组30例与雾化组39例,两组患儿均采用基础治疗,雾化组患儿另外予以盐酸氨溴索联合利巴韦林雾化吸入治疗,日2次,连用7天。观察两组患儿呼吸改善、肺部湿啰音消失、肺功能改善,住院天数及治疗效果。结果:雾化组患儿咳嗽、气促及肺部啰音改善情况好于对照组,平均住院天数少于对照组,肺功能改善优于对照组,治疗1周后的临床疗效优于对照组。结论:盐酸氨溴索联合利巴韦林雾化吸入是治疗小儿毛细支气管炎的有效方法。

Objective：To observe the curative effect and nursing of the patients with bronchiolitis treated with inhalation with ambroxol and ribavirin.Methods：69 cases of bronchiolitis were randomly divided into control group（30 cases） and inhalation group（36 cases）.All patients in the control group were treated with routine methods.In addition,all patients in the inhalation group were treated with inhalation of ambroxol and ribavirin twice daily for 7 d.The respiratory improvement,changes of lung rales,hospitalization days,lung function improvement of the children in the two groups were compared.Results：The improvement of cough,shortness of breath and rales were better in the inhalation group than in the control group.The average length of hospital stay was shorter,and the improvement of lung function was better in the inhalation group too.The treatment efficacy after 1 week of the inhilation group was superior to the control group.Conclusion：Inhalation with ambroxol and ribavirin is an effective treatment for children bronchiolitis.